Related references
Note: Only part of the references are listed.Evidence for pituitary adenylate cyclase-activating peptide as a direct immunoregulator in teleost head kidney
Xinyan Wang et al.
FISH & SHELLFISH IMMUNOLOGY (2013)
PACAP induces the dimerization of PAC1 on the nucleus associated with the cAMP increase in the nucleus
Rongjie Yu et al.
NEUROSCIENCE LETTERS (2013)
Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide
Ngoc-Duc Doan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38
Michael Baun et al.
CEPHALALGIA (2012)
Design and characterization of novel cell-penetrating peptides from pituitary adenylate cyclase-activating polypeptide
Ngoc-Duc Doan et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects
Ngoc-Duc Doan et al.
BIOCHEMICAL PHARMACOLOGY (2011)
CART peptide stimulation of G protein-mediated signaling in differentiated PC12 Cells: Identification of PACAP 6-38 as a CART receptor antagonist
Yiming Lin et al.
NEUROPEPTIDES (2011)
Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures
Joseph R. Cohen et al.
BMC CANCER (2010)
Molecular and Conformational Determinants of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) for Activation of the PAC1 Receptor
Steve Bourgault et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
D. Vaudry et al.
PHARMACOLOGICAL REVIEWS (2009)
Effects of PACAP and VIP on cAMP-generating System and Proliferation of C6 Glioma Cells
Paulina Sokolowska et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
Agonistic Behavior of PACAP6-38 on Sensory Nerve Terminals and Cytotrophoblast Cells
D. Reglodi et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
Novel stable PACAP analogs with potent activity towards the PAC1 receptor
Steve Bourgault et al.
PEPTIDES (2008)
Induction of colitis and rapid development of colorectal tumors in mice deficient in the neuropeptide PACAP
Nicole Nemetz et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
VIP and PACAP are autocrine factors that protect the androgenindependent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawal
I Gutiérrez-Cañas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides -: In vivo metabolism of pituitary adenylate cyclase-activating polypeptide-(1-38)
L Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Share Paper
